
    
      Patients from both sexes, 18 to 65 years of age, diagnosed with simple or complex partial
      onset epileptic crisis defined according to the International League Against Epilepsy (ILAE)
      criteria, with a minimum of two seizures within the 4 previous weeks, a stable treatment with
      two antiepileptic drugs for at least 12 weeks, and capable and willing to give their informed
      consent, will be included in the study.

      To these patients, physicians will prescribe zonisamide in the following manner: Titration
      period of 12 weeks, at the end of which all patients must be taking 300 mg. Maintenance doses
      period of 12 weeks, at the beginning of which, physicians will decide to keep the 300 mg dose
      from the titration period, lower it to 200 mg, or take it up to 400 mg. Six weeks later
      within this period, a decision will be made to raise the 400 mg doses up to 500 mg if
      considered necessary and tolerable.

      Drugs will be prescribed by the physician and purchased by the patient.
    
  